UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas

Nuclear medicine and biology, 2010-10, Vol.37 (7), p.785-794

2010

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a cell-based fluorescent method for measuring antibody affinity

Journal of immunological methods, 2017-03, Vol.442, p.49-53

2017

Link zum Volltext

Verfügbarkeit prüfen

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma

Journal of clinical neuroscience, 2014-01, Vol.21 (1), p.189-190

2014

Link zum Volltext

Verfügbarkeit prüfen

GMab-1, a high-affinity anti-3′-isoLM1/3′,6′-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice

Biochemical and biophysical research communications, 2010-01, Vol.391 (1), p.750-755

2010

Link zum Volltext

Verfügbarkeit prüfen

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

Biochemical and biophysical research communications, 2009-12, Vol.390 (3), p.547-551

2009

Link zum Volltext

Verfügbarkeit prüfen

Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab

Nuclear medicine and biology, 2009-08, Vol.36 (6), p.659-669

2009

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors

Nuclear medicine and biology, 2012-01, Vol.39 (1), p.23-34

2012

Link zum Volltext

Verfügbarkeit prüfen

Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[ 211At]astato-3-pyridinecarboxylate

Nuclear medicine and biology, 1999-05, Vol.26 (4), p.405-411

1999

Link zum Volltext

Verfügbarkeit prüfen

Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Nuclear medicine and biology, 2010-10, Vol.37 (7), p.741-750

2010

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma

Journal of neuroimmunology, 2000-02, Vol.103 (1), p.16-25

2000

Link zum Volltext

Verfügbarkeit prüfen

Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance

Nuclear medicine and biology, 2006, Vol.33 (1), p.101-110

2006

Link zum Volltext

Verfügbarkeit prüfen

Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate

Nuclear medicine and biology, 2002, Vol.29 (1), p.1-11

2002

Link zum Volltext

Verfügbarkeit prüfen

Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Nuclear medicine and biology, 2007-02, Vol.34 (2), p.173-183

2007

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[ 131i]iodo-4-phosphonomethylbenzoate ([ 131i]SIPMB), a negatively charged substituent bearing acylation agent

Nuclear medicine and biology, 2004-10, Vol.31 (7), p.909-919

2004

Link zum Volltext

Verfügbarkeit prüfen

A monoclonal antibody IMab-1 specifically recognizes IDH1{sup R132H}, the most common glioma-derived mutation

Biochemical and biophysical research communications, 2009-12, Vol.390 (3)

2009

Link zum Volltext

Verfügbarkeit prüfen

Design of a Novel Small Peptide Targeted against a Tumor-Specific Receptor

Biochemical and biophysical research communications, 2000-08, Vol.275 (2), p.631-636

2000

Link zum Volltext

Verfügbarkeit prüfen

Positively charged templates for labeling internalizing antibodies : comparison of N-succinimidyl 5-iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR

Nuclear medicine and biology, 2001-10, Vol.28 (7), p.769-777

2001

Link zum Volltext

Verfügbarkeit prüfen

A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo

Journal of neuroimmunology, 1997-09, Vol.78 (1), p.34-46

1997

Link zum Volltext

Verfügbarkeit prüfen

Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin

Journal of neuroimmunology, 1994-07, Vol.52 (2), p.127-137

1994

Link zum Volltext

Verfügbarkeit prüfen

Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an α-particle-emitting immunoconjugate

Nuclear medicine and biology, 1997-04, Vol.24 (3), p.255-261

1997

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo behavior of radiolabeled chimeric anti-EGFRvIII monoclonal antibody: Comparison with its murine parent

Nuclear medicine and biology, 1997-10, Vol.24 (7), p.639-647

1997

Link zum Volltext

Verfügbarkeit prüfen

Radiotoxicity of systemically administered [211AT]astatide in B6C3F1 and BALB/c (nu/nu) mice : A long-term survival study with histologic analysis

International journal of radiation oncology, biology, physics, 1996-04, Vol.35 (1), p.69-80

1996

Link zum Volltext

Verfügbarkeit prüfen

Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis

International journal of radiation oncology, biology, physics, 1999-09, Vol.45 (2), p.491-499

1999

Link zum Volltext

Verfügbarkeit prüfen

Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent

Nuclear medicine and biology, 1996-05, Vol.23 (4), p.449-458

1996

Link zum Volltext

Verfügbarkeit prüfen

Radiotoxicity of systemically administered [ 211At]astatide in B6C3F 1 and BALB/ c ( nu/nu) mice: A long-term survival study with histologic analysis

International journal of radiation oncology, biology, physics, 1996, Vol.35 (1), p.69-80

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Zeitschrift / SerieCancer Research

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Animals
(29)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(19)
Biological And Medical Sciences
(18)
Medical Sciences
(15)
Tissue Distribution
(14)
Mice, Inbred Balb C
(11)
Radioimmunotherapy
(11)
Mice, Nude
(10)
Radiology, Nuclear Medicine & Medical Imaging
(10)
Antibodies, Monoclonal - Pharmacokinetics
(9)
Cell Line, Tumor
(9)
Glioma - Metabolism
(9)
Female
(8)
Monoclonal Antibodies
(8)
Monoclonal Antibody
(8)
Pharmacology. Drug Treatments
(8)
Neoplasm Transplantation
(7)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(31)
Elsevier ScienceDirect Journals Complete
(31)
MEDLINE
(29)
IngentaConnect Journals
(5)
Journals@Ovid Complete
(1)

Menü

Weitere Dienste

Einstellungen

Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas

Development and validation of a cell-based fluorescent method for measuring antibody affinity

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma

GMab-1, a high-affinity anti-3′-isoLM1/3′,6′-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab

Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors

Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[ 211At]astato-3-pyridinecarboxylate

Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma

Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance

Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate

Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[ 131i]iodo-4-phosphonomethylbenzoate ([ 131i]SIPMB), a negatively charged substituent bearing acylation agent

A monoclonal antibody IMab-1 specifically recognizes IDH1{sup R132H}, the most common glioma-derived mutation

Design of a Novel Small Peptide Targeted against a Tumor-Specific Receptor

Positively charged templates for labeling internalizing antibodies : comparison of N-succinimidyl 5-iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR

A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo

Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin

Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an α-particle-emitting immunoconjugate

In vitro and in vivo behavior of radiolabeled chimeric anti-EGFRvIII monoclonal antibody: Comparison with its murine parent

Radiotoxicity of systemically administered [211AT]astatide in B6C3F1 and BALB/c (nu/nu) mice : A long-term survival study with histologic analysis

Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis

Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent

Radiotoxicity of systemically administered [ 211At]astatide in B6C3F 1 and BALB/ c ( nu/nu) mice: A long-term survival study with histologic analysis

Aktive Filter

Suchergebnisse filtern